81 related articles for article (PubMed ID: 25481773)
21. Author Correction: Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer.
Sauriol SA; Carmona E; Udaskin ML; Radulovich N; Leclerc-Desaulniers K; Rottapel R; Oza AM; Lheureux S; Provencher DM; Mes-Masson AM
Sci Rep; 2024 May; 14(1):10017. PubMed ID: 38693303
[No Abstract] [Full Text] [Related]
22. The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.
Weng Z; Patel AB; Panagiotidou S; Theoharides TC
J Allergy Clin Immunol; 2015 Apr; 135(4):1044-1052.e5. PubMed ID: 25498791
[TBL] [Abstract][Full Text] [Related]
23. IL-4 Protects the Mitochondria Against TNFα and IFNγ Induced Insult During Clearance of Infection with Citrobacter rodentium and Escherichia coli.
Maiti AK; Sharba S; Navabi N; Forsman H; Fernandez HR; Lindén SK
Sci Rep; 2015 Oct; 5():15434. PubMed ID: 26481427
[TBL] [Abstract][Full Text] [Related]
24. TNF-α regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells.
Prajapati P; Sripada L; Singh K; Bhatelia K; Singh R; Singh R
Biochim Biophys Acta; 2015 Mar; 1852(3):451-61. PubMed ID: 25481834
[TBL] [Abstract][Full Text] [Related]
25. Hypertension exacerbates predisposition to neurodegeneration and memory impairment in the presence of a neuroinflammatory stimulus: Protection by angiotensin converting enzyme inhibition.
Goel R; Bhat SA; Rajasekar N; Hanif K; Nath C; Shukla R
Pharmacol Biochem Behav; 2015 Jun; 133():132-45. PubMed ID: 25869103
[TBL] [Abstract][Full Text] [Related]
26. Effect of homeopathic Lycopodium clavatum on memory functions and cerebral blood flow in memory-impaired rats.
Hanif K; Kumar M; Singh N; Shukla R
Homeopathy; 2015 Jan; 104(1):24-8. PubMed ID: 25576268
[TBL] [Abstract][Full Text] [Related]
27. Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension.
Malenfant S; Potus F; Fournier F; Breuils-Bonnet S; Pflieger A; Bourassa S; Tremblay È; Nehmé B; Droit A; Bonnet S; Provencher S
J Mol Med (Berl); 2015 May; 93(5):573-84. PubMed ID: 25548805
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary arterial hypertension in rats due to age-related arginase activation in intermittent hypoxia.
Nara A; Nagai H; Shintani-Ishida K; Ogura S; Shimosawa T; Kuwahira I; Shirai M; Yoshida K
Am J Respir Cell Mol Biol; 2015 Aug; 53(2):184-92. PubMed ID: 25490411
[TBL] [Abstract][Full Text] [Related]
29. Comparative transcription profiling of mRNA and lncRNA in pulmonary arterial hypertension after C75 treatment.
Hou C; Xie L; Wang T; Zheng J; Zhao Y; Qiu Q; Yang Y; Xiao T
BMC Pulm Med; 2023 Jan; 23(1):46. PubMed ID: 36717804
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection.
Dash S; Dash C; Pandhare J
Noncoding RNA; 2021 Sep; 7(4):. PubMed ID: 34698261
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial Protection by PARP Inhibition.
Gallyas F; Sumegi B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316192
[TBL] [Abstract][Full Text] [Related]
32. New and Emerging Therapies for Pulmonary Arterial Hypertension.
Spiekerkoetter E; Kawut SM; de Jesus Perez VA
Annu Rev Med; 2019 Jan; 70():45-59. PubMed ID: 30216732
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs Modulate Oxidative Stress in Hypertension through PARP-1 Regulation.
Dluzen DF; Kim Y; Bastian P; Zhang Y; Lehrmann E; Becker KG; Noren Hooten N; Evans MK
Oxid Med Cell Longev; 2017; 2017():3984280. PubMed ID: 28660007
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus.
Atlı Ö; Ilgın S; Ergun B; Burukoğlu D; Musmul A; Sırmagül B
Anatol J Cardiol; 2017 Jan; 17(1):8-17. PubMed ID: 27182612
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of fatty acid synthase is protective in pulmonary hypertension.
Singh N; Manhas A; Kaur G; Jagavelu K; Hanif K
Br J Pharmacol; 2016 Jun; 173(12):2030-45. PubMed ID: 27061087
[TBL] [Abstract][Full Text] [Related]
36. Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
Kaur G; Singh N; Lingeshwar P; Siddiqui HH; Hanif K
Pulm Pharmacol Ther; 2015 Feb; 30():66-79. PubMed ID: 25481773
[TBL] [Abstract][Full Text] [Related]
37. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
38. Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation.
Wani WY; Sunkaria A; Sharma DR; Kandimalla RJ; Kaushal A; Gerace E; Chiarugi A; Gill KD
Neuroscience; 2014 Jan; 258():1-15. PubMed ID: 24231740
[TBL] [Abstract][Full Text] [Related]
39. Melatonin as a preventive and curative therapy against pulmonary hypertension.
Maarman G; Blackhurst D; Thienemann F; Blauwet L; Butrous G; Davies N; Sliwa K; Lecour S
J Pineal Res; 2015 Oct; 59(3):343-53. PubMed ID: 26201290
[TBL] [Abstract][Full Text] [Related]
40. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
